Healthcare & Life Sciences
Evolvere BioSciences
United Kingdom
seed
seed
Stage
1
Investors
About
Evolvere BioSciences uses computational models and AI to develop next-generation antibiotics that can predict bacterial mutations and design therapies targeting pathogenic bacteria without harming beneficial microbes or human cells.
Explore Evolvere BioSciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.